Westlake Village-based biotech firm Sienna Biopharmaceuticals announced Feb. 8 that one of its clinical-stage products has shown positive trial results for hair removal. Shares rose more than 5 percent on the news that the topical pre-treatment for laser hair removal, SNA-001, had demonstrated up to 31 percent reduction of light hair, opening up a potential…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
